Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine.

Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine.

Item
http://www.wikidata.org/entity/Q43693786
Persistence and compliance with medication management in the treatment of overactive bladderPharmacoeconomic evaluation of antimuscarinic agents for the treatment of overactive bladderOxybutynin and tolterodine in a trial for treatment of overactive bladder in Iranian womenEvidence for the efficacy and safety of tolterodine in the treatment of overactive bladder.Current pharmacotherapeutic strategies for overactive bladder.Tolterodine for the treatment of overactive bladder: a review.A meta-analysis comparing trials of antimuscarinic medications funded by industry or not.Darifenacin for the treatment of overactive bladder.Clinical study results of tolterodine in patients with overactive bladder.Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature.Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder.Cost effectiveness of fesoterodine and tolterodine for the treatment of overactive bladder with urge urinary incontinence in Spain and Finland.Sustained improvement in patient-reported outcomes during long-term fesoterodine treatment for overactive bladder symptoms: pooled analysis of two open-label extension studies.Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged ≥ 75 years) with overactive bladder syndrome.Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients.Tolterodine: as effective but better tolerated than oxybutynin in Asian patients with symptoms of overactive bladder.Considering the prominent complaint as a guide in medical therapy for overactive bladder syndrome in women over 45 years.
P2860

Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine.

Item
http://www.wikidata.org/entity/Q43693786
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine.
@en
Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine.
@nl
type
label
Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine.
@en
Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine.
@nl
prefLabel
Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine.
@en
Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine.
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine.
@en
P2093
P2888
P304
P31
P356
10.2165/00002512-200118070-00007
P433
P478
P577
P6179
P698